Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5224)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 26, 2021 (publication date) through Jun 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He SY, Lin QF, Chen J, Yu GP, Zhang JL, Shen D. Efficacy of afatinib in a patient with rare EGFR (G724S/R776H) mutations and amplification in lung adenocarcinoma: A case report. World J Clin Cases 2021; 9(6): 1329-1335 [PMID: 33644199 DOI: 10.12998/wjcc.v9.i6.1329] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i6/1329.htm |
| Number | Citing Articles |
| 1 |
Mateo Sanchis-Borja, Florian Guisier, Aurélie Swalduz, Hubert Curcio, Victor Basse, Christophe Maritaz, Christos Chouaid, Jean-Bernard Auliac. Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France. OncoTargets and Therapy 2024; : 439 doi: 10.2147/OTT.S448909
|
| 2 |
Tianli Wang, Qin Zheng, Cong Deng, Xiang Li, Jia Huang, Jun Fan, Bo Huang, Jiwei Zhang, Xiaona Chang, Xiu Nie. Identification of EGFR R776H germline mutations in a patient with multifocal lung adenocarcinoma: A case report and literature review. Respiratory Medicine Case Reports 2024; 50: 102051 doi: 10.1016/j.rmcr.2024.102051
|
| 3 |
Nian Yu, Yinghui Xu, Xu Wang, Chao Sun, Shi Qiu, Ye Guo, Miao Bai, Yanxin Huang, Kewei Ma. Successful Treatment of Afatinib Reversing Epidermal Growth Factor ReceptorExon19Deletion/G724S MutationResistance Guided byProtein-DrugDocking. The Oncologist 2021; 26(11): e1903 doi: 10.1002/onco.13932
|
| 4 |
Sara Boukansa, Ismail Mouhrach, Fatima El Agy, Laila Bouguenouch, Mounia Serraj, Bouchra Amara, Yassine Ouadnouni, Mohamed Smahi, Badreeddine Alami, Nawfel Mellas, Zineb Benbrahim, Hinde El Fatemi. An epidermal growth factor receptor compound mutation of L858R with S768I in advanced non-small-cell lung cancer: a case report. Journal of Medical Case Reports 2024; 18(1) doi: 10.1186/s13256-024-04422-5
|
| 5 |
Teng Li, Shouzheng Wang, Jianming Ying, Yan Wang, Xingsheng Hu, Xuezhi Hao, Ziyi Xu, Puyuan Xing, Junling Li. Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutations. Thoracic Cancer 2021; 12(21): 2924 doi: 10.1111/1759-7714.14156
|
| 6 |
Iacopo Petrini, Rossella Bruno, Iosè Di Stefano, Vittorio Aprile, Stylianos Korasidis, Eleonora Pardini, Antonio Chella, Greta Alì. A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers Harboring Different Somatic EGFR Mutations. Clinical Lung Cancer 2024; doi: 10.1016/j.cllc.2024.04.007
|
| 7 |
Joyce Cui, Sana Tabbara, Juskaran Chadha. The broad spectrum of tyrosine kinase inhibitors. Treatment of a rare EGFR R776H mutation with Osimertinib: Case report. SAGE Open Medical Case Reports 2023; 11 doi: 10.1177/2050313X231196663
|
| 8 |
Justin Lin Sovich, Tu Dan, Amber Gemmell, Cheyla Clark, Jeffrey Gagan, Jonathan E. Dowell. Lung Adenocarcinoma Associated With Germline EGFR R776H Variant: A Case Report and Review of the Literature. JCO Precision Oncology 2022; (6) doi: 10.1200/PO.21.00559
|